Patents by Inventor David Samuel Larsen

David Samuel Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11072584
    Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: July 27, 2021
    Assignee: Otago Innovation Limited
    Inventors: Ivan Andrew Sammut, Joanne Clare Harrison, Russell James Hewitt, Morgayn Iona Read, Nathan John Stanley, Laura Molly Woods, Jui Thiang Brian Kueh, Morgan Jay-Smith, Robin Andrew James Smith, Gregory Giles, Lesley Larsen, David Rennison, Margaret Anne Brimble, David Samuel Larsen
  • Publication number: 20200109115
    Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
    Type: Application
    Filed: December 3, 2019
    Publication date: April 9, 2020
    Inventors: Ivan Andrew SAMMUT, Joanne Clare HARRISON, Russell James HEWITT, Morgayn Iona READ, Nathan John STANLEY, Laura Molly WOODS, Jui Thiang Brian KUEH, Morgan JAY-SMITH, Robin Andrew James SMITH, Gregory GILES, Lesley LARSEN, David RENNISON, Margaret Anne BRIMBLE, David Samuel LARSEN
  • Patent number: 10494344
    Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: December 3, 2019
    Assignee: Otago Innovation Limited
    Inventors: Ivan Andrew Sammut, Joanne Clare Harrison, Russell James Hewitt, Morgayn Iona Read, Nathan John Stanley, Laura Molly Woods, Jui Thiang Brian Kueh, Morgan Jay-Smith, Robin Andrew James Smith, Gregory Giles, Lesley Larsen, David Rennison, Margaret Anne Brimble, David Samuel Larsen
  • Publication number: 20180346420
    Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.
    Type: Application
    Filed: November 30, 2016
    Publication date: December 6, 2018
    Inventors: Ivan Andrew SAMMUT, Joanne Clare HARRISON, Russell James HEWITT, Morgayn Iona READ, Nathan John STANLEY, Laura Molly WOODS, Jui Thiang Brian KUEH, Morgan JAY-SMITH, Robin Andrew James SMITH, Gregory GILES, Lesley LARSEN, David RENNISON, Margaret Anne BRIMBLE, David Samuel LARSEN
  • Patent number: 9764037
    Abstract: The invention relates to sphingoglycolipid analogs and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: September 19, 2017
    Assignee: Victoria Link Limited
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Franca Ronchese
  • Patent number: 9717790
    Abstract: The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: August 1, 2017
    Assignee: Victoria Link Limited
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, Karen Anne Johnston, David Samuel Larsen, Gavin Frank Painter
  • Patent number: 9586985
    Abstract: This invention relates to sphingoglycolipid analogs, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: March 7, 2017
    Assignee: VICTORIA LINK LIMITED
    Inventors: Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Regan J. Anderson
  • Publication number: 20160136267
    Abstract: The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Application
    Filed: June 10, 2014
    Publication date: May 19, 2016
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, Karen Anne Johnston, David Samuel Larsen, Gavin Frank Painter
  • Publication number: 20150352219
    Abstract: The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
    Type: Application
    Filed: December 6, 2013
    Publication date: December 10, 2015
    Inventors: Regan James Anderson, Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Franca Ronchese
  • Publication number: 20150191503
    Abstract: This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 9, 2015
    Inventors: Benjamin Jason Compton, Colin Malcolm Hayman, Ian Francis Hermans, David Samuel Larsen, Gavin Frank Painter, Regan J. Anderson
  • Patent number: 7989602
    Abstract: The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosaccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disorders.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: August 2, 2011
    Assignees: The Malaghan Institute of Medical Research, University of Otago, Agresearch Limited
    Inventors: Gurmit Singh-Gill, David Samuel Larsen, Jeremy David Jones, Wayne Bruce Severn, Jacquie Lucille Harper, Gavin Painter
  • Publication number: 20080249037
    Abstract: The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disorders.
    Type: Application
    Filed: November 18, 2004
    Publication date: October 9, 2008
    Inventors: Gurmit Singh-Gill, David Samuel Larsen, Jeremy David Jones, Wayne Bruce Severn, Jacquie Lucille Harper, Gavin Painter